The Moderna, Inc. (MRNA) revenue growth is (44.3%), which is lower than the industry median of 13.4% and the 5-year historical average of 2,163.7%.
The Moderna, Inc. (MRNA) operating income growth is 1.1%, compared to the industry median of 1.1% and the 5-year historical average of 228.7%.
The Moderna, Inc. (MRNA) EPS growth is (36.5%), compared to the industry median of (20.2%) and the 5-year historical average of 212.9%.
The Moderna, Inc. (MRNA) Free Cash Flow growth is 48.9%, compared to the industry median of (1.2%) and the 5-year historical average of 229.2%.